Experimental osteodystrophy of chronic renal failure induced by aluminum‐ and ferric‐nitrilotriacetate in Wistar rats
- 1 January 1995
- journal article
- research article
- Published by Wiley in Pathology International
- Vol. 45 (1), 19-25
- https://doi.org/10.1111/j.1440-1827.1995.tb03375.x
Abstract
The aluminum (AI) and iron (Fe) chelate complexes of nitrilotriacetate (NTA) cause renal insufficiency when they are administered intraperitoneally to rats. Their effects on bone metabolism were studied in 4 week old Wistar rats. Daily intraperitoneal administration of AI-NTA (3mg AI/kg for 11 weeks) induced osteomalacia, impaired bone growth, decreased bone mineral density, lower serum PTH levels than normal as well as renal insufficiency. Al staining showed diffuse deposition in the trabecula and a strong linear band of aluminum deposited at the mineralization front and along the cement line. The osteoid seen markedly within the trabecula was probably the decalcified portion of the bone, the calcium apatite of which was defectively fabricated because of diffuse Al deposition in the trabecula. Al deposition along the cement line would make it much more susceptible to external shear stress than normal. Although daily intraperitoneal administration of Fe-NTA (6 mg Fe/kg for 11 weeks) caused impaired bone growth, decreased bone mineral content and renal insufficiency, the osteoid volume did not increase. Fe staining showed that Fe was deposited diffusely in the cytoplasm of osteoblasts. The results of this study demonstrated that during renal insufficiency, different minerals exhibit different modes of action on bone metabolism, and that Al-NTA is useful for experimental animal models of Al-induced osteomalacia in renal insufficiency.Keywords
This publication has 20 references indexed in Scilit:
- Impairment of bone formation with aluminum and ferric nitrilotriacetate complexesCalcified Tissue International, 1991
- Clinical Studies Using a Highly Sensitive Radioimmunoassay for Mid-Region and Carboxy Terminus of Parathyroid Hormone in Normal, Hypo-and Hypercalcemic StatesFolia Endocrinologica Japonica, 1989
- Liver, kidney, and central nervous system toxicity of aluminum given intraperitoneally to rats: A multiple-dose subchronic study using aluminum nitrilotriacetateToxicology and Applied Pharmacology, 1984
- Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolismKidney International, 1984
- Effect of aluminum on normal and uremic rats: Tissue distribution, vitamin D metabolites, and quantitative bone histologyCalcified Tissue International, 1983
- Animal model of aluminum-induced osteomalacia: Role of chronic renal failureKidney International, 1983
- Bone Aluminum and Histomorphometric Features of Renal Osteodystrophy*Journal of Clinical Endocrinology & Metabolism, 1982
- Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralizationKidney International, 1981
- Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.Journal of Clinical Pathology, 1979
- The Effect of Aluminium Hydroxide on Calcium, Phosphorus and Aluminium Balances, the Serum Parathyroid Hormone Concentration and the Aluminium Content of Bone in Patients with Chronic Renal FailureClinical Science, 1972